Iceland Cools SpikeVax COVID-19 Vaccinations
Iceland's Directorate of Health announced on October 8, 2021, as there is a sufficient supply of Pfizer vaccine (Comirnaty) available in Iceland for both the pre-vaccine activation vaccines and the primary vaccinations of those who have not yet been vaccinated, the Epidemiologist has decided that the Moderna (SpikeVax) vaccine will not be used in Iceland.
In recent days, there has been data from the Nordic countries on the increased incidence of myocarditis and pericarditis after vaccination with Moderna and Pfizer / BioNTech vaccines.
This heart issue seems to apply regardless of which mRNA vaccine was given as the first dose, reported Norway.
And in Sweden, the use of Moderna has recently been restricted to individuals born before 1991.
Iceland's Health leaders have only recommended the Pfizer / BioNTech vaccine for primary vaccination at 12–17 years.
Additional news from Iceland's Health Directorate is available at this weblink.